Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.27681 | 10 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.2243 | 9 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.22777 | 9 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.17213 | 9 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.16717 | 9 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.29082 | 10 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.25406 | 9 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.19806 | 9 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.19004 | 9 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.21055 | 9 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.21118 | 9 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.19514 | 9 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.21733 | 9 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.21638 | 9 |